Company news

Devonian Health Group, Inc. news in 2025

Devonian Health Group, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Devonian Health Group Announces Grant of Stock Options

December 19, 2025

Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update

December 12, 2025

Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent

December 4, 2025

Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member

November 26, 2025

Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units

October 21, 2025

Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement

August 22, 2025

Devonian Announces Closing of a Private Placement of Units

August 7, 2025

Devonian Health Group Reports Third Quarter 2025 Financial Results

June 26, 2025

Devonian Appoints New Officers and Announces Grant of Stock Options

June 9, 2025

Devonian Health Group Announces Reinstatement of Quotation on the TSXV

April 28, 2025

Devonian Health Group Reports Second Quarter 2025 Financial Results

April 15, 2025

Devonian Health Group Reports Cease Trade Order

April 14, 2025

Devonian Reports Delay of Financial Reporting

April 1, 2025

Devonian Reports Results of its Annual General and Special Meeting of Shareholders

March 24, 2025

Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent

February 19, 2025

Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis

February 18, 2025

Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine(TM) for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)